Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (1620)	6/5/2003 10:35:41 PM
From: Miljenko Zuanic	Read Replies (1) of 3044

<< But they have managed the clinical development and regulatory work in an excellent way.>> Sure that did. As well as preclinical models and studies, biology, mechanisms, and all other things that are part of the drug development. Investment in basic science always pay off when you get bit of the luck down the road. Because of the MLNM own infrastructure they can explore Velcade (from genomic-pharmacogenomic to predictive and personalized medicine) in a way that no pharma or bios can do it today. This is advantage. I hope that they will apply some methodology on all candidates. Restructuring and layoff was expected, due to cease of the collaborative revenue. Focus on commercialization infrastructure is OK, but one should not forget those that make commercialization possible in first place. Many prefer scraping candidates from other when they do not have resource to move forward, it may be cheaper. Well, that is the case for now. Will hold tomorrow? Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next